Publication Information

{'id': 'https://openalex.org/W2025315044', 'doi': 'https://doi.org/10.1016/s0022-5347(01)67243-4', 'title': 'Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension: A Double-Blind, Placebo-Controlled, Dose-Response Multicenter Study', 'display_name': 'Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension: A Double-Blind, Placebo-Controlled, Dose-Response Multicenter Study', 'publication_year': 1995, 'publication_date': '1995-07-01', 'ids': {'openalex': 'https://openalex.org/W2025315044', 'doi': 'https://doi.org/10.1016/s0022-5347(01)67243-4', 'mag': '2025315044', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/7539854'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0022-5347(01)67243-4', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5038342473', 'display_name': 'Jay Y. Gillenwater', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I51556381', 'display_name': 'University of Virginia', 'ror': 'https://ror.org/0153tk833', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I51556381']}, {'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jay Y. Gillenwater', 'raw_affiliation_strings': ['Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.'], 'affiliations': [{'raw_affiliation_string': 'Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.', 'institution_ids': ['https://openalex.org/I51556381', 'https://openalex.org/I180857899', 'https://openalex.org/I8692664']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063636972', 'display_name': 'Richard Conn', 'orcid': 'https://orcid.org/0000-0002-2564-254X'}, 'institutions': [{'id': 'https://openalex.org/I51556381', 'display_name': 'University of Virginia', 'ror': 'https://ror.org/0153tk833', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I51556381']}, {'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard L. Conn', 'raw_affiliation_strings': ['Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.'], 'affiliations': [{'raw_affiliation_string': 'Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.', 'institution_ids': ['https://openalex.org/I51556381', 'https://openalex.org/I180857899', 'https://openalex.org/I8692664']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076355849', 'display_name': 'Steven G. Chrysant', 'orcid': 'https://orcid.org/0000-0001-9972-7151'}, 'institutions': [{'id': 'https://openalex.org/I51556381', 'display_name': 'University of Virginia', 'ror': 'https://ror.org/0153tk833', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I51556381']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}, {'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Steven G. Chrysant', 'raw_affiliation_strings': ['Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.'], 'affiliations': [{'raw_affiliation_string': 'Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.', 'institution_ids': ['https://openalex.org/I51556381', 'https://openalex.org/I8692664', 'https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104038715', 'display_name': 'Johnny Roy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I51556381', 'display_name': 'University of Virginia', 'ror': 'https://ror.org/0153tk833', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I51556381']}, {'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Johnny Roy', 'raw_affiliation_strings': ['Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.'], 'affiliations': [{'raw_affiliation_string': 'Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.', 'institution_ids': ['https://openalex.org/I51556381', 'https://openalex.org/I180857899', 'https://openalex.org/I8692664']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102721357', 'display_name': 'Michael Gaffney', 'orcid': 'https://orcid.org/0000-0002-7552-6942'}, 'institutions': [{'id': 'https://openalex.org/I51556381', 'display_name': 'University of Virginia', 'ror': 'https://ror.org/0153tk833', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I51556381']}, {'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael Gaffney', 'raw_affiliation_strings': ['Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.'], 'affiliations': [{'raw_affiliation_string': 'Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.', 'institution_ids': ['https://openalex.org/I51556381', 'https://openalex.org/I180857899', 'https://openalex.org/I8692664']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007856506', 'display_name': 'Kathleen Ice', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I51556381', 'display_name': 'University of Virginia', 'ror': 'https://ror.org/0153tk833', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I51556381']}, {'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kathleen Ice', 'raw_affiliation_strings': ['Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.'], 'affiliations': [{'raw_affiliation_string': 'Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.', 'institution_ids': ['https://openalex.org/I51556381', 'https://openalex.org/I180857899', 'https://openalex.org/I8692664']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5044818790', 'display_name': 'Norma Dias', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I51556381', 'display_name': 'University of Virginia', 'ror': 'https://ror.org/0153tk833', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I51556381']}, {'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}, {'id': 'https://openalex.org/I8692664', 'display_name': 'University of Oklahoma', 'ror': 'https://ror.org/02aqsxs83', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I8692664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Norma Dias', 'raw_affiliation_strings': ['Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.'], 'affiliations': [{'raw_affiliation_string': 'Departments of Urology, University of Virginia Medical School, Charlottesville, Virginia, Lovelace Scientific Resources Inc., Albuquerque, New Mexico, Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma, Oklahoma City, Oklahoma, and Pfizer Central Research, New York, New York.', 'institution_ids': ['https://openalex.org/I51556381', 'https://openalex.org/I180857899', 'https://openalex.org/I8692664']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 15.079, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 189, 'citation_normalized_percentile': {'value': 0.949958, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '154', 'issue': '1', 'first_page': '110', 'last_page': '115'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10279', 'display_name': 'Urinary Bladder and Prostate Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2748', 'display_name': 'Urology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10279', 'display_name': 'Urinary Bladder and Prostate Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2748', 'display_name': 'Urology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11146', 'display_name': 'Hormonal and reproductive studies', 'score': 0.9681, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11950', 'display_name': 'Cardiovascular Syncope and Autonomic Disorders', 'score': 0.9603, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/doxazosin', 'display_name': 'Doxazosin', 'score': 0.8618946}], 'concepts': [{'id': 'https://openalex.org/C2777590997', 'wikidata': 'https://www.wikidata.org/wiki/Q419939', 'display_name': 'Doxazosin', 'level': 3, 'score': 0.8618946}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7570202}, {'id': 'https://openalex.org/C2777562237', 'wikidata': 'https://www.wikidata.org/wiki/Q835051', 'display_name': 'Hyperplasia', 'level': 2, 'score': 0.59401137}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.5123876}, {'id': 'https://openalex.org/C2992435398', 'wikidata': 'https://www.wikidata.org/wiki/Q6934595', 'display_name': 'Multicenter study', 'level': 3, 'score': 0.46590123}, {'id': 'https://openalex.org/C74909509', 'wikidata': 'https://www.wikidata.org/wiki/Q10387', 'display_name': 'Gerontology', 'level': 1, 'score': 0.39884472}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.27806455}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.18526533}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.13115582}, {'id': 'https://openalex.org/C84393581', 'wikidata': 'https://www.wikidata.org/wiki/Q82642', 'display_name': 'Blood pressure', 'level': 2, 'score': 0.09957805}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.08364037}], 'mesh': [{'descriptor_ui': 'D017292', 'descriptor_name': 'Doxazosin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D006973', 'descriptor_name': 'Hypertension', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': True}, {'descriptor_ui': 'D011470', 'descriptor_name': 'Prostatic Hyperplasia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001794', 'descriptor_name': 'Blood Pressure', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D001794', 'descriptor_name': 'Blood Pressure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017292', 'descriptor_name': 'Doxazosin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D017292', 'descriptor_name': 'Doxazosin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D017292', 'descriptor_name': 'Doxazosin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006339', 'descriptor_name': 'Heart Rate', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D006339', 'descriptor_name': 'Heart Rate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006973', 'descriptor_name': 'Hypertension', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D006973', 'descriptor_name': 'Hypertension', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017060', 'descriptor_name': 'Patient Satisfaction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010919', 'descriptor_name': 'Placebos', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011446', 'descriptor_name': 'Prospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011470', 'descriptor_name': 'Prostatic Hyperplasia', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D011470', 'descriptor_name': 'Prostatic Hyperplasia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012449', 'descriptor_name': 'Safety', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014554', 'descriptor_name': 'Urination', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D014554', 'descriptor_name': 'Urination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014555', 'descriptor_name': 'Urination Disorders', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D014555', 'descriptor_name': 'Urination Disorders', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0022-5347(01)67243-4', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7539854', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 24, 'referenced_works': ['https://openalex.org/W101374796', 'https://openalex.org/W1586519380', 'https://openalex.org/W1965186415', 'https://openalex.org/W1971806877', 'https://openalex.org/W2026238971', 'https://openalex.org/W2037776386', 'https://openalex.org/W2038819520', 'https://openalex.org/W2039935433', 'https://openalex.org/W2052122168', 'https://openalex.org/W2054403476', 'https://openalex.org/W2065433275', 'https://openalex.org/W2067041008', 'https://openalex.org/W2084886742', 'https://openalex.org/W2094977125', 'https://openalex.org/W2132291525', 'https://openalex.org/W2138705852', 'https://openalex.org/W2249623265', 'https://openalex.org/W2405592102', 'https://openalex.org/W2413445666', 'https://openalex.org/W2414598931', 'https://openalex.org/W2418950777', 'https://openalex.org/W2419306660', 'https://openalex.org/W4256004280', 'https://openalex.org/W50194971'], 'related_works': ['https://openalex.org/W83502726', 'https://openalex.org/W3152270497', 'https://openalex.org/W2442745377', 'https://openalex.org/W2387719349', 'https://openalex.org/W2132954942', 'https://openalex.org/W2092999665', 'https://openalex.org/W2052990160', 'https://openalex.org/W2035946033', 'https://openalex.org/W2030805271', 'https://openalex.org/W1984248391'], 'abstract_inverted_index': {'No': [0], 'AccessJournal': [1], 'of': [2, 12, 96, 144, 179, 221, 236, 246, 258, 317, 324, 357, 378, 399, 419, 424, 429, 445, 479, 487, 492, 507, 529, 552, 580, 598, 607, 622, 625, 680, 701, 718, 733, 754, 757, 777, 810, 840, 870, 874, 904, 927, 965, 1007, 1046, 1088, 1126, 1160, 1202, 1217], 'UrologyClinical': [3], 'Urology:': [4], 'Original': [5], 'Article1': [6], 'Jul': [7], '1995Doxazosin': [8], 'for': [9, 363, 443, 578, 604, 684, 806, 1189], 'the': [10, 234, 244, 256, 290, 397, 420, 427, 464, 480, 485, 508, 571, 605, 623], 'Treatment': [11], 'Benign': [13, 268, 807, 837, 1190], 'Prostatic': [14, 808, 838, 1191], 'Hyperplasia': [15], 'in': [16, 112, 131, 153, 167, 214, 218, 243, 255, 289, 311, 339, 342, 381, 396, 426, 463, 484, 512, 538, 627, 657, 703, 720, 741, 831, 896, 1197], 'Patients': [17], 'with': [18, 105, 163, 173, 201, 206, 644, 659, 802], 'Mild': [19], 'to': [20, 88, 137, 185, 212, 540], 'Moderate': [21], 'Essential': [22], 'Hypertension:': [23], 'A': [24, 94, 402, 414, 527, 563, 617, 662, 676, 715, 863, 951, 1021, 1023], 'Double-Blind,': [25], 'Placebo-Controlled,': [26], 'Dose-Response': [27], 'Multicenter': [28, 1295], 'Study': [29, 496, 1296], 'Jay': [30, 48, 1248], 'Y.': [31, 49, 51, 1249], 'Gillenwater,': [32], 'Richard': [33, 54, 1256], 'L.': [34, 55, 57, 1257, 1331, 1358], 'Conn,': [35, 1332], 'Steven': [36, 60, 1264], 'G.': [37, 61, 63, 1265, 1309, 1372, 1379, 1383], 'Chrysant,': [38], 'Johnny': [39, 66, 1272], 'Roy,': [40, 1313], 'Michael': [41, 70, 1279], 'Gaffney,': [42], 'Kathleen': [43, 74, 1286], 'Ice,': [44], 'and': [45, 78, 149, 152, 159, 192, 225, 263, 286, 295, 319, 336, 361, 422, 477, 514, 532, 535, 573, 602, 699, 743, 772, 775, 782, 822, 828, 836, 864, 890, 916, 947, 985, 1019, 1064, 1108, 1146, 1184, 1195, 1199, 1301, 1311, 1322, 1361, 1371, 1388, 1393], 'Norma': [46, 79, 1293], 'Dias': [47, 81, 1185, 1294], 'GillenwaterJay': [50], 'Gillenwater': [52, 1250], ',': [53, 59, 65, 69, 73, 77], 'ConnRichard': [56], 'Conn': [58, 1258], 'ChrysantSteven': [62], 'Chrysant': [64, 1266, 1310], 'RoyJohnny': [67], 'Roy': [68, 1273], 'GaffneyMichael': [71], 'Gaffney': [72, 1180, 1280], 'IceKathleen': [75], 'Ice': [76, 1182, 1287], 'DiasNorma': [80], 'View': [82], 'All': [83, 1407], 'Author': [84, 1246], 'Informationhttps://doi.org/10.1016/S0022-5347(01)67243-4AboutFull': [85], 'TextPDF': [86], 'ToolsAdd': [87], 'favoritesDownload': [89], 'CitationsTrack': [90], 'CitationsPermissionsReprints': [91], 'ShareFacebookLinked': [92], 'InTwitterEmail': [93], 'total': [95], '248': [97], 'hypertensive': [98], 'patients': [99, 222, 259, 658], '45': [100], 'years': [101], 'old': [102], 'or': [103], 'older': [104], 'benign': [106, 312, 343, 358, 382, 430, 446, 488, 581, 628, 685], 'prostatic': [107, 269, 293, 313, 340, 344, 359, 383, 400, 431, 447, 489, 582, 629, 660, 686], 'hyperplasia': [108, 360], '(BPH)': [109], 'was': [110, 171, 198], 'included': [111], 'this': [113, 1254, 1262, 1270, 1277, 1284, 1291, 1404], '16-week,': [114], 'multicenter,': [115], 'double-blind,': [116], 'placebo-controlled,': [117], 'parallel-group': [118], 'dose-response': [119], 'study.': [120, 404, 665], 'Doxazosin,': [121], 'a': [122, 128, 239], 'selective': [123], 'alpha': [124, 459], '1-adrenoceptor': [125], 'antagonist,': [126], 'produced': [127], 'significant': [129, 172], 'increase': [130, 166], 'maximum': [132, 168], 'urinary': [133], 'flow': [134, 155, 169], 'rate': [135, 156, 170], '(2.3': [136], '3.6': [138], 'ml.': [139], 'per': [140], 'second)': [141], 'at': [142, 566], 'doses': [143, 204], '4': [145, 332, 956], 'mg.,': [146, 151], '8': [147, 412, 958], 'mg.': [148, 158], '12': [150, 160, 504], 'average': [154], '(8': [157], 'mg.)': [161], 'compared': [162, 184, 205], 'placebo.': [164, 207, 229], 'The': [165, 309, 376, 449, 595], 'doxazosin': [174, 203, 224, 237, 483, 681, 702, 719, 734], 'versus': [175, 600], 'placebo': [176, 186], 'within': [177], 'week': [178], 'initiating': [180], 'double-blind': [181, 663, 678], 'therapy.': [182, 705], 'Doxazosin': [183, 249, 495, 655, 1188], 'significantly': [187, 199], 'decreased': [188], 'patient-assessed': [189], 'total,': [190], 'obstructive': [191], 'irritative': [193], 'BPH': [194, 262], 'symptoms.': [195], 'Blood': [196], 'pressure': [197, 338], 'lower': [200], 'all': [202], 'Adverse': [208], 'events,': [209], 'primarily': [210], 'mild': [211, 539], 'moderate': [213, 541], 'severity,': [215], 'were': [216], 'reported': [217], '48': [219], 'percent': [220, 227], 'on': [223, 228, 735], '35': [226], 'Our': [230], 'results': [231], 'strongly': [232], 'support': [233], 'use': [235, 377], 'as': [238, 682], 'nonoperative': [240], 'therapeutic': [241, 364, 536], 'alternative': [242], 'management': [245, 257], 'uncomplicated': [247], 'BPH.': [248, 515, 609, 744], 'would': [250], 'also': [251], 'be': [252], 'particularly': [253], 'useful': [254], 'who': [260], 'have': [261], 'hypertension.': [264, 542], 'References': [265], '1': [266, 460, 1231], ':': [267, 284, 308, 315, 333, 354, 375, 394, 413, 441, 458, 475, 505, 525, 549, 562, 594, 616, 639, 654, 675, 697, 714, 731], 'hyperplasia.': [270, 432, 490], 'In:': [271], '.': [272], 'Philadelphia:': [273], 'W.': [274, 1299, 1303], 'B.': [275], 'Saunders': [276], 'Co.1992:': [277], '1009.': [278], 'chapt.': [279], '25.': [280], 'Google': [281, 305, 330, 351, 372, 391, 410, 438, 455, 472, 502, 522, 546, 559, 591, 613, 636, 651, 672, 694, 711, 728, 751], 'Scholar': [282, 306, 331, 352, 373, 392, 411, 439, 456, 473, 503, 523, 547, 560, 592, 614, 637, 652, 673, 695, 712, 729, 752], '2': [283, 1032], 'Adrenergic': [285], 'cholinergic': [287], 'receptors': [288], 'human': [291, 465], 'prostate,': [292], 'capsule': [294, 310], 'bladder': [296, 567], 'neck.': [297], 'Brit.': [298, 385, 405, 467, 516, 631, 646, 689, 745], 'J.': [299, 346, 386, 406, 433, 468, 517, 555, 632, 647, 667, 690, 707, 724, 746, 1302, 1312, 1337, 1351, 1357, 1367, 1389], 'Urol.1975;': [300], '47:': [301], '193.': [302], 'Crossref,': [303], 'Medline,': [304, 390], '3': [307, 1131], 'hypertrophy.': [314, 345, 448, 583], 'Department': [316], 'Health': [318, 325], 'Human': [320, 872], 'Services,': [321], 'National': [322], 'Institutes': [323], 'Publication': [326], 'No.': [327], '87-28811987:': [328], '221.': [329], 'Alpha-adrenergic': [334], 'activity': [335], 'urethral': [337], 'zone': [341], 'Urol.1982;': [347, 648], '128:': [348], '836.': [349], 'Link,': [350, 437], '5': [353, 493], 'Clinical': [355], 'manifestations': [356], 'indications': [362], 'intervention.': [365], 'Urol.': [366, 668], 'Clin.': [367, 518, 747], 'N.': [368], 'Amer.1990;': [369], '17:': [370], '509.': [371], '6': [374], 'alpha-adrenergic': [379], 'blockers': [380], 'obstruction.': [384, 401, 630, 661, 688], 'Urol.1976;': [387], '48:': [388], '255.': [389], '7': [393], 'Prazosin': [395], 'treatment': [398, 428, 444, 486, 606, 656, 683], 'placebo-controlled': [403, 416, 618, 664], 'Urol.1987;': [407], '60:': [408], '136.': [409], 'randomized,': [415], 'multicenter': [417, 716], 'study': [418, 621, 679], 'efficacy': [421, 537, 597], 'safety': [423, 478, 700], 'terazosin': [425, 599, 601], 'Urol.1992;': [434], '148:': [435], '1467.': [436], '9': [440], 'Alfuzosin': [442], 'BPH-ALF': [450], 'Group.': [451, 497], 'Lancet1991;': [452], '337:': [453], '1457.': [454], '10': [457], 'Adrenoceptor': [461], 'subtypes': [462], 'prostate.': [466], 'Urol.1994;': [469, 691], '74:': [470, 520, 692, 749], '585.': [471], '11': [474], 'Efficacy': [476, 698, 1194], 'alpha-1': [481], 'blocker': [482], 'Analysis': [491], 'studies.': [494], 'Eur.': [498], 'Urol.1993;': [499], '24:': [500], '319.': [501], 'Role': [506], 'sympathetic': [509], 'nervous': [510], 'system': [511], 'hypertension': [513, 704, 742], 'Pract.1994;': [519, 748], '13.': [521], '13': [524], 'Doxazosin.': [526], 'review': [528], 'its': [530], 'pharmacodynamic': [531], 'pharmacokinetic': [533], 'properties': [534], 'Drugs1988;': [543], '35:': [544], '525.': [545], '14': [548], 'Pharmacokinetic': [550], 'overview': [551], 'doxazosin.': [553], 'Amer.': [554, 585, 706, 723], 'Cardiol.1987;': [556, 708, 725], '59:': [557, 709, 726], '78G.': [558], '15': [561], 'new': [564], 'look': [565], 'neck': [568], 'obstruction': [569, 642], 'by': [570, 791, 1241, 1253, 1261, 1269, 1276, 1283, 1290, 1403], 'Food': [572], 'Drug': [574], 'Administration': [575], 'regulators:': [576], 'guidelines': [577], 'investigation': [579], 'Trans.': [584], 'Ass.': [586], 'Genito-Urin.': [587], 'Surg.1977;': [588], '68:': [589], '29.': [590], '16': [593], 'relative': [596], 'flutamide': [603], 'symptomatic': [608], 'Prostate1992;': [610], '20:': [611], '89.': [612], '17': [615], 'double': [619], 'blind': [620], 'effect': [624], 'phenoxybenzamine': [626], 'Urol.1978;': [633], '50:': [634], '551.': [635], '18': [638], 'Bladder': [640, 901], 'outflow': [641], 'treated': [643], 'phenoxybenzamine.': [645], '54:': [649], '527.': [650], '19': [653], 'Scand.': [666], 'Nephrol.1993;': [669], '27:': [670], '39.': [671], '20': [674], 'three-month': [677], 'outlet': [687], '50.': [693], '21': [696], '35G.': [710], '22': [713], 'trial': [717], 'West': [721], 'Germany.': [722], '40G.': [727], '23': [730], 'Effects': [732], 'coronary': [736], 'heart': [737], 'disease': [738], 'risk': [739], 'factors': [740], '8.': [750], 'Departments': [753], 'Urology,': [755, 811, 841, 875, 905, 928, 966, 1008, 1047, 1089, 1127, 1161, 1203, 1218], 'University': [756, 776], 'Virginia': [758], 'Medical': [759], 'School,': [760], 'Charlottesville,': [761], 'Virginia,': [762], 'Lovelace': [763], 'Scientific': [764], 'Resources': [765], 'Inc.,': [766], 'Albuquerque,': [767, 1333], 'New': [768, 786, 788, 1326, 1328, 1334, 1343, 1355, 1375], 'Mexico,': [769], 'Oklahoma': [770, 779, 1314], 'Cardiovascular': [771], 'Hypertension': [773], 'Center': [774], 'Oklahoma,': [778, 781], 'City,': [780, 1315], 'Pfizer': [783], 'Central': [784], 'Research,': [785], 'York,': [787, 1327], 'York.©': [789], '1995': [790, 1233, 1240], 'American': [792, 1242], 'Urological': [793, 1243], 'Association,': [794, 1244], 'Inc.FiguresReferencesRelatedDetailsCited': [795], 'byKaplan': [796], 'S': [797, 915, 984, 1148], '(2016)': [798], 'Re:': [799], 'Stroke': [800], 'Associated': [801], 'Alpha': [803], 'Blocker': [804], 'Therapy': [805], 'HypertrophyJournal': [809], 'VOL.': [812, 842, 876, 906, 929, 967, 1009, 1048, 1090, 1128, 1162, 1204, 1219], '196,': [813], 'NO.': [814, 844, 878, 908, 931, 969, 1011, 1050, 1092, 1130, 1164, 1206, 1221], '1,': [815, 1133, 1222], '(192-193),': [816], 'Online': [817, 847, 881, 911, 934, 972, 1014, 1053, 1095, 1135, 1167, 1209, 1224], 'publication': [818, 848, 882, 912, 935, 973, 1015, 1054, 1096, 1136, 1168, 1210, 1225], 'date:': [819, 849, 883, 913, 936, 974, 1016, 1055, 1097, 1137, 1169, 1211, 1226], '1-Jul-2016.ROEHRBORN': [820], 'C': [821, 889, 1063], 'SCHWINN': [823], 'D': [824, 949], '(2018)': [825, 867, 893, 919, 950, 988, 1022, 1067, 1111, 1149, 1187, 1213], 'α1-Adrenergic': [826, 894], 'Receptors': [827], 'Their': [829], 'Inhibitors': [830], 'Lower': [832], 'Urinary': [833], 'Tract': [834], 'Symptoms': [835], 'HyperplasiaJournal': [839], '171,': [843], '3,': [845, 879], '(1029-1035),': [846], '1-Mar-2004.KESTER': [850], 'R,': [851, 940, 944], 'MOOPPAN': [852], 'U,': [853], 'GOUSSE': [854], 'A,': [855, 978, 980, 1143, 1179], 'ALVER': [856], 'J,': [857, 859, 976, 982, 1141], 'GINTAUTAS': [858], 'GULMI': [860], 'F,': [861], 'ABADIR': [862], 'KIM': [865], 'H': [866], 'Pharmacological': [868], 'Characterization': [869], 'Isolated': [871], 'ProstateJournal': [873], '170,': [877], '(1032-1038),': [880], '1-Sep-2003.Yang': [884], 'S,': [885, 938, 942, 1173], 'Wang': [886], 'C,': [887], 'Hsieh': [888], 'Chen': [891], 'Y': [892], 'Blockers': [895], 'Young': [897], 'Men': [898], 'With': [899], 'Primary': [900], 'Neck': [902], 'ObstructionJournal': [903], '168,': [907], '2,': [909, 932, 1207], '(571-574),': [910], '1-Aug-2002.MARINKOVIC': [914], 'BADLANI': [917], 'G': [918], 'VOIDING': [920], 'AND': [921, 992, 1081, 1084], 'SEXUAL': [922], 'DYSFUNCTION': [923], 'AFTER': [924], 'CEREBROVASCULAR': [925], 'ACCIDENTSJournal': [926], '165,': [930], '(359-370),': [933], '1-Feb-2001.MacDIARMID': [937], 'EMERY': [939], 'FERGUSON': [941], 'McGUIRT-FRANKLIN': [943], 'McINTYRE': [945], 'W': [946], 'JOHNSON': [948], 'RANDOMIZED': [952], 'DOUBLE-BLIND': [953], 'STUDY': [954, 1030], 'ASSESSING': [955], 'VERSUS': [957], 'MG.': [959], 'DOXAZOSIN': [960, 993, 1155], 'FOR': [961], 'BENIGN': [962, 1004, 1043, 1157], 'PROSTATIC': [963, 1005, 1044, 1158], 'HYPERPLASIAJournal': [964, 1006, 1045, 1159], '162,': [968], '5,': [970, 1051], '(1629-1632),': [971], '1-Nov-1999.CHON': [975], 'BORKOWSKI': [977, 1142], 'PARTIN': [979], 'ISAACS': [981], 'JACOBS': [983, 1147], 'KYPRIANOU': [986], 'N': [987, 1186], 'alpha1-ADRENOCEPTOR': [989], 'ANTAGONISTS': [990], 'TERAZOSIN': [991], 'INDUCE': [994], 'PROSTATE': [995, 1152], 'APOPTOSIS': [996, 1153], 'WITHOUT': [997], 'AFFECTING': [998], 'CELL': [999], 'PROLIFERATION': [1000], 'IN': [1001, 1038, 1156], 'PATIENTS': [1002, 1039, 1116], 'WITH': [1003, 1040, 1117], '161,': [1010], '6,': [1012, 1165], '(2002-2008),': [1013], '1-Jun-1999.NARAYAN': [1017], 'P': [1018], 'TEWARI': [1020], 'SECOND': [1024], 'PHASE': [1025], 'III': [1026], 'MULTICENTER': [1027], 'PLACEBO': [1028], 'CONTROLLED': [1029], 'OF': [1031, 1034, 1042, 1070, 1079, 1114, 1151], 'DOSAGES': [1033], 'MODIFIED': [1035], 'RELEASE': [1036], 'TAMSULOSIN': [1037, 1112], 'SYMPTOMS': [1041], '160,': [1049, 1091, 1129], '(1701-1706),': [1052], '1-Nov-1998.LEPOR': [1056], 'H,': [1057, 1103, 1105, 1171], 'WILLIFORD': [1058], 'W,': [1059], 'BARRY': [1060], 'M,': [1061, 1099, 1181], 'HAAKENSON': [1062], 'JONES': [1065], 'K': [1066, 1183], 'THE': [1068], 'IMPACT': [1069], 'MEDICAL': [1071], 'THERAPY': [1072], 'ON': [1073], 'BOTHER': [1074], 'DUE': [1075], 'TO': [1076], 'SYMPTOMS,': [1077], 'QUALITY': [1078], 'LIFE': [1080], 'GLOBAL': [1082], 'OUTCOME,': [1083], 'FACTORS': [1085], 'PREDICTING': [1086], 'RESPONSEJournal': [1087], '4,': [1093], '(1358-1367),': [1094], '1-Oct-1998.MICHEL': [1098], 'MEHLBURGER': [1100], 'L,': [1101], 'BRESSEL': [1102], 'SCHUMACHER': [1104], 'SCHAFERS': [1106], 'R': [1107, 1145], 'GOEPEL': [1109], 'M': [1110], 'TREATMENT': [1113], '19,365': [1115], 'LOWER': [1118], 'URINARY': [1119], 'TRACT': [1120], 'SYMPTOMS:': [1121], 'DOES': [1122], 'CO-MORBIDITY': [1123], 'ALTER': [1124], 'TOLERABILITY?Journal': [1125], 'Part': [1132], '(784-791),': [1134], '1-Sep-1998.KYPRIANOU': [1138], 'N,': [1139], 'LITVAK': [1140], 'ALEXANDER': [1144], 'INDUCTION': [1150], 'BY': [1154, 1215], '159,': [1163], '(1810-1815),': [1166], '1-Jun-1998.Lepor': [1170], 'Kaplan': [1172], 'Klimberg': [1174], 'I,': [1175], 'Mobley': [1176], 'D,': [1177], 'Fawzy': [1178], 'Hyperplasia:': [1192], 'Long-term': [1193], 'Safety': [1196], 'Hypertensive': [1198], 'Normotensive': [1200], 'PatientsJournal': [1201], '157,': [1205], '(525-530),': [1208], '1-Feb-1997.': [1212], 'REPLY': [1214], 'AUTHORSJournal': [1216], '154,': [1220], '(109-109),': [1223], '1-Jul-1995.': [1227], 'Volume': [1228], '154': [1229], 'Issue': [1230], 'July': [1232], 'Page:': [1234], '110-115': [1235], 'Advertisement': [1236, 1408], 'Copyright': [1237], '&': [1238], 'Permissions©': [1239], 'Inc.Metrics': [1245], 'Information': [1247], 'More': [1251, 1259, 1267, 1274, 1281, 1288, 1401], 'articles': [1252, 1260, 1268, 1275, 1282, 1289, 1402], 'author': [1255, 1263, 1271, 1278, 1285, 1292, 1405], 'Group:': [1297], 'T.': [1298, 1318], 'Ayres': [1300], 'Wescott,': [1304], 'Daytona': [1305], 'Beach,': [1306], 'Florida;': [1307], 'S.': [1308, 1323, 1346, 1368], 'Oklahoma;': [1316], 'A.': [1317, 1324, 1341, 1352], 'K.': [1319], 'Cockett,': [1320], 'Rochester': [1321], 'Kaplan,': [1325], 'York;': [1329], 'R.': [1330, 1336, 1362, 1363], 'Mexico;': [1335], 'Correa,': [1338], 'Seattle,': [1339], 'Washington;': [1340], 'Fawzy,': [1342], 'Orleans,': [1344], 'Louisiana;': [1345], 'D.': [1347, 1390], 'Graham,': [1348], 'Atlanta,': [1349], 'Georgia;': [1350], 'Heaney,': [1353], 'Hanover,': [1354], 'Hampshire;': [1356], 'Holtzman,': [1359], 'Minneapolis': [1360], 'Moyer,': [1364], 'Hibbing,': [1365], 'Minnesota;': [1366], 'Isen,': [1369], 'Worcester': [1370], 'P.': [1373, 1378], 'Lewis,': [1374], 'Bedford,': [1376], 'Massachusetts;': [1377], 'Katz,': [1380], 'Richmond,': [1381], 'Virginia;': [1382], 'H.': [1384], 'Malek,': [1385], 'Madison,': [1386], 'Wisconsin;': [1387], 'McConnell,': [1391], 'Dallas': [1392], 'I.': [1394], 'M.': [1395], 'Thompson,': [1396], 'Fort': [1397], 'Sam': [1398], 'Houston,': [1399], 'Texas.': [1400], 'Expand': [1406], 'PDF': [1409], 'downloadLoading': [1410], '...': [1411]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2025315044', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 4}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 8}], 'updated_date': '2024-12-15T14:35:49.232586', 'created_date': '2016-06-24'}